Crabs (Pubic Lice): Prevention and Treatment

Pubic lice (commonly called "crabs") are parasitic insects that infest hair-bearing skin in the pubic region and occasionally other coarse hair-bearing areas. Although not life-threatening, infestations cause significant discomfort and can lead to secondary skin infection. This article reviews the clinical features, transmission, diagnosis, treatment, environmental control, prevention strategies, and special considerations for pubic lice, with guidance based on current clinical sources (Mayo Clinic, Cleveland Clinic, National Institutes of Health/MedlinePlus, American College of Obstetricians and Gynecologists).

Overview and epidemiology

Pubic lice are caused by the insect Pthirus pubis. The adult insects are small and adapted to grasp coarse hair. Infestations occur worldwide and affect people of all genders and ages after the onset of pubertal body hair. Transmission is most commonly via close personal contact, including sexual activity, but nonsexual transmission via fomites (shared bedding, towels, or clothing) can occur less commonly.

Prevalence varies by population and region. Although less common than head lice, pubic lice remain an important cause of pruritus in the genital region. Because pubic lice are often associated with sexual contact, evaluation for other sexually transmitted infections (STIs) is frequently considered in affected individuals (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Life cycle and biology

Understanding the life cycle helps guide treatment and environmental measures:

  • Eggs (nits): Female lice lay small eggs attached to hair shafts near the skin. Eggs require warmth and humidity to develop and typically hatch in approximately 6–10 days.
  • Nymphs: Newly hatched nymphs resemble small adults and mature over 2–3 weeks through several molts.
  • Adults: Adult lice feed on human blood and live on the host’s hair and skin. On the human body they can survive for up to about 30 days while continuously feeding; off the human host they typically survive 24–48 hours, and eggs removed from the body do not hatch unless incubated near body temperature.

Reference sources provide similar timeframes and describe that lice are obligate human parasites that require blood meals to survive (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Transmission

Modes of transmission include:

  • Close bodily contact: The most common route is prolonged close skin-to-skin contact, including sexual contact, which allows lice to move from one person to another.
  • Fomites: Less commonly, lice can be transmitted via sharing contaminated bedding, towels, or clothing that has recently been in contact with an infested person. Because lice lose viability off the body within 1–2 days, indirect transmission is less frequent than direct contact.
  • Spread to other body sites: Pubic lice can also colonize other coarse hair-bearing sites such as axillary hair, beard, mustache, chest hair, and, rarely, eyebrows or eyelashes, particularly in young children or when grooming habits differ.

Transmission patterns have implications for partner notification, contact management, and environmental control measures (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Clinical presentation: symptoms and signs

The hallmark symptom is pruritus (itching) in the affected area. Itching may be mild or intense and often worsens at night when lice are more active.

Common findings include:

  • Intense itching in the pubic or other affected hair-bearing areas.
  • Visible lice or nits attached to hair shafts. Nits are small, oval, and usually firmly attached to the hair close to the skin.
  • Erythema, excoriations, and petechiae from scratching.
  • Small bluish-gray macules (maculae caeruleae) in the pubic region may represent a localized reaction to lice saliva; these may persist after treatment.
  • Secondary bacterial infection: Excoriation from scratching may become secondarily infected, producing pain, purulent drainage, and local erythema—this may require antibiotic therapy.

Onset of symptoms varies. If adult lice are present, itching and rash may be immediate. If only eggs are present, symptoms may take 2–4 weeks to develop as nymphs and adults emerge. Infestations are equally common in all genders after puberty (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Diagnosis

Diagnosis is usually clinical and can often be made by visualization:

  • Direct inspection: Careful inspection of the pubic hair and other coarse hair under good lighting can reveal motile lice or attached eggs.
  • Magnification: Dermoscopy or a magnifying lens can assist in identifying lice or nits.
  • Microscopy: Plucked hairs or material from the affected area can be examined under a microscope to confirm the presence of lice or eggs when diagnosis is uncertain.

It is important to distinguish viable nits (which are close to the skin and more translucent) from empty shells or debris. Consultation with a clinician is recommended when the diagnosis is unclear or when eyelashes/eyelids are involved (Mayo Clinic; Cleveland Clinic).

Differential diagnosis

Conditions that can mimic pubic lice include:

  • Scabies (Sarcoptes scabiei) – produces intense nocturnal itching and burrows, but scabies typically affects finger webs, wrists, and flexural areas and does not produce nits attached to hair shafts.
  • Contact dermatitis – localized dermatitis from irritants or allergens may cause itching and erythema without visible lice or nits.
  • Folliculitis or other bacterial skin infections – may cause follicular inflammation and pustules.
  • Tinea (fungal infections) – may cause pruritic lesions in the groin (tinea cruris), but lesions are usually scaling and annular.

Accurate diagnosis guides appropriate therapy and avoids unnecessary treatments (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Treatment principles

Treatment goals are to eradicate lice, kill eggs or remove nits, relieve symptoms, prevent reinfestation, and treat secondary infection if present. Effective management combines pharmacologic therapy directed at the host plus measures to address clothing, bedding, and close contacts.

Key treatment components:

  • Topical pediculicides: First-line therapy for most people.
  • Systemic therapy: Considered for treatment failures or when topical therapy is impractical.
  • Eyelid involvement: Managed with special measures to avoid ocular toxicity.
  • Environmental control: Laundering, heat drying, or sealing items to prevent reinfestation.
  • Treatment of recent sexual contacts and counseling to abstain from sexual activity until therapy is complete.

Clinical recommendations may vary slightly among sources; the following summarizes commonly accepted approaches (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus; ACOG).

First-line topical treatments

Commonly used topical agents include:

  • Permethrin 1% cream rinse: Applied to the affected area and washed off per product directions. Permethrin blocks insect neuronal sodium channels leading to paralysis and death of lice. A single application often suffices, but a repeat application in 7–10 days is frequently recommended if live lice are still observed after the first treatment.
  • Pyrethrins with piperonyl butoxide: An alternative topical option available in some regions. Applied as directed and often repeated if live lice persist.

Application details, duration, and repeat dosing recommendations vary with product; follow the product label and clinician instructions. Local adverse effects may include mild burning, stinging, or irritation. Permethrin creams are generally well tolerated (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Note: Over-the-counter shampoo formulations formulated for head lice may not be labeled for pubic lice. Use medications specifically recommended for pubic lice or as advised by a clinician.

Alternative and systemic therapy

  • Oral ivermectin: An oral antiparasitic medication that may be used for treatment failures, widespread infestation, or when topical therapy is impractical. Typical dosing for lice is a single dose of ivermectin 200 mcg/kg, with a repeat dose after 7–14 days in many regimens. Ivermectin is generally not recommended during pregnancy or in young children; consult a clinician before use. Some resistant cases may require systemic therapy (Cleveland Clinic; NIH/MedlinePlus).
  • Malathion: An organophosphate topical agent used for lice in some settings; not commonly first-line for pubic lice and may have restrictions depending on pregnancy and product availability.

Choice of agent depends on local availability, patient factors (pregnancy, breastfeeding, age, allergies), and clinician judgment. When using any prescription or over-the-counter pediculicide, follow the product label and healthcare provider instructions.

Management of eyelash or eyelid involvement

When pubic lice infest eyelashes or eyelids, topical pediculicides intended for skin should not be used near the eye due to risk of ocular toxicity.

Recommended approaches include:

  • Mechanical removal: Carefully removing visible lice and nits with fine forceps after local anesthesia or under medical supervision.
  • Ophthalmic measures: Application of petrolatum (lubricating) ointment to the eyelid margins twice daily for 10 days to suffocate lice is commonly used; refer to an ophthalmologist for confirmation and management.
  • Specialist consultation: Referral to an ophthalmologist is advisable for eyelid or eyelash infestations, particularly in children.

Do not apply routine topical pediculicides intended for the body to the eye area (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Treating secondary infection and symptomatic relief

  • Secondary bacterial infection: If there are signs of secondary infection (increasing pain, warmth, purulent drainage, systemic symptoms), topical or systemic antibiotics may be necessary after clinical evaluation.
  • Symptom relief: Topical antipruritic agents, cold compresses, or short courses of topical corticosteroids prescribed by a clinician may reduce itching and inflammation. Avoid vigorous scratching to reduce the risk of secondary infection.

Managing contacts and preventing reinfestation

  • Sexual partners and close contacts: Individuals who have had close contact with the person in the preceding month (particularly sexual partners) should be informed, evaluated, and treated if appropriate. All sexual partners within the previous month typically should be treated to prevent reinfestation.
  • Abstain from sexual activity: Avoid sexual contact until treatment of all affected persons is completed and inspection indicates eradication.
  • Environmental measures:
  • Launder clothing, towels, and bedding used within the prior 2 days in hot water and dry on the highest possible heat setting; heat effectively kills lice and eggs.
  • Items that cannot be washed may be dry-cleaned or sealed in plastic bags for 72 hours to ensure lice cannot survive.
  • Vacuum furniture and carpets to remove hairs with attached lice or nits.
  • Avoid sharing clothing, towels, and bedding until treatment is complete.
  • Re-inspection: Re-examine the treated areas 1–2 weeks after therapy to ensure eradication; retreat if live lice are detected.

Following these measures reduces the risk of reinfestation and spread (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Special populations and pregnancy considerations

  • Pregnancy and breastfeeding: Some topical pediculicides, such as permethrin, are considered acceptable in pregnancy when indicated, but systemic agents (e.g., oral ivermectin) are generally avoided during pregnancy and lactation unless benefits outweigh risks. Discuss options with an obstetric provider. The American College of Obstetricians and Gynecologists recommends individualized assessment for pregnant patients with parasitic infestations (ACOG; NIH/MedlinePlus).
  • Children: In young children, particularly when eyelashes are affected, consult a pediatrician or pediatric ophthalmologist. Many topical agents are not approved for use in very young children.
  • Immunocompromised patients: May experience more extensive infestation; systemic therapy and specialist consultation may be required.

Always seek individualized medical advice when treating special populations (ACOG; Mayo Clinic; Cleveland Clinic).

Treatment failure and resistance

Persistent infestation after appropriate therapy may be due to:

  • Improper application of topical therapy (insufficient contact time, not treating all affected areas).
  • Failure to treat close contacts, leading to reinfestation.
  • Incomplete environmental measures.
  • Rarely, insecticide resistance.

If lice persist after appropriate treatment, consult a clinician for alternative regimens (e.g., oral ivermectin, alternative topical agents) and confirmation of diagnosis (Mayo Clinic; Cleveland Clinic).

Complications

Complications are uncommon but include:

  • Secondary bacterial infection from excoriation.
  • Psychological distress related to infestation and privacy concerns.
  • Rarely, dermatitis or allergic reactions to topical treatments.

Timely diagnosis and treatment minimize complications (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

Prevention: practical recommendations

  • Practice safe personal hygiene and avoid sharing personal items such as towels, undergarments, and bedding.
  • Inform and treat recent sexual partners to prevent spread.
  • Use barriers such as condoms do not reliably prevent transmission because lice live in pubic hair beyond areas covered by condoms. Therefore, the main prevention is limiting direct skin-to-skin contact with an infested person and avoiding sharing contaminated items.
  • Perform routine inspection of pubic hair and other coarse hair if symptoms arise.
  • Consider STI screening when pubic lice are diagnosed given shared modes of transmission with other sexually transmitted infections (Mayo Clinic; Cleveland Clinic; NIH/MedlinePlus).

When to see a healthcare provider

Seek medical evaluation if any of the following occur:

  • Intense or persistent itching in the pubic area or other hair-bearing sites.
  • Visible lice or nits on inspection.
  • Signs of secondary infection such as increasing pain, redness, swelling, pus, or fever.
  • Eyelash/eyelid involvement.
  • Concerns about pregnancy, breastfeeding, or treatment in young children.
  • Recurrent or treatment-resistant infestation.

Prompt consultation enables appropriate diagnosis, treatment, and partner notification.

Common questions (FAQs)

  • How long after treatment can I resume sexual activity?
  • Abstain from sexual activity until both you and your sexual partners have completed treatment and follow-up shows no live lice; typically after a single effective topical treatment and absence of live lice on recheck, but follow your clinician’s advice.
  • Can pubic lice be transmitted via toilet seats?
  • Transmission from inanimate objects such as toilet seats is unlikely because lice do not survive well off the human body. Most transmission occurs through close personal contact and, less commonly, via recently contaminated bedding or clothing.
  • Will I need STI testing?
  • Because pubic lice are commonly transmitted during sexual contact, clinicians often consider offering screening for other STIs based on sexual history and risk factors.

Key takeaways

  • Pubic lice are parasitic insects causing pruritus in the pubic region and other coarse hair-bearing areas; diagnosis is typically by visualization of lice or nits.
  • First-line treatment usually involves topical pediculicides (e.g., permethrin 1% cream rinse or pyrethrins with piperonyl butoxide), with repeat dosing or alternative agents (including oral ivermectin) for treatment failures.
  • Eyelash involvement requires ophthalmologic attention and mechanical or occlusive measures rather than standard topical pediculicides.
  • Treat recent sexual contacts, launder clothing and bedding, and follow environmental measures to prevent reinfestation.
  • Consult a healthcare provider for diagnosis, treatment recommendations tailored to pregnancy, children, or treatment-resistant cases, and for evaluation of possible coexisting sexually transmitted infections.

References and resources for patient and clinician information:

  • Mayo Clinic. Pubic lice (crabs) — Symptoms and causes; Treatments. https://www.mayoclinic.org
  • Cleveland Clinic. Pubic Lice (Crabs): Overview, Symptoms, Causes, Treatment. https://my.clevelandclinic.org
  • National Institutes of Health (MedlinePlus). Pubic lice — Patient information. https://medlineplus.gov
  • American College of Obstetricians and Gynecologists (ACOG). Practice guidance on parasitic infections in pregnancy (patient guidance and committee opinions). https://www.acog.org

(Note: Product formulations, dosing recommendations, and clinical guidelines may change. Always follow current product labeling and consult licensed healthcare professionals for individualized management.)